Medico Remedies Announces 32nd AGM on Sep 22, 2026; Re-appointment of Directors
Medico Remedies Limited will hold its 32nd AGM on September 22, 2026. Key agenda items include the re-appointment of directors Mr. Haresh Kapurlal Mehta and Mr. Rishit Haresh Mehta, and an increase in remuneration for Mr. Harshit Mehta and Ms. Priyal Rishit Mehta and Ms. Shweta Harshit Mehta. Remuneration for key managerial personnel is capped at ₹7,50,000 per month.
The re-appointment of key management personnel and adjustments to their remuneration are significant for the company's governance and operational continuity. The AGM also involves the approval of financial statements, which is a material event for shareholders.
The announcement pertains to routine corporate governance matters like the AGM, re-appointment of directors, and remuneration adjustments. While these are important, they do not inherently suggest a positive or negative shift in the company's performance or outlook.
Medico Remedies Limited has announced its 32nd Annual General Meeting (AGM) to be held on Tuesday, 22nd September, 2026, at 4:00 p.m. through Video Conferencing (VC) / Other Audio Visual Means (OAVM). The company has submitted its Annual Report for the financial year 2025-26 along with the Notice of the AGM.
Key agenda items for the AGM include the adoption of audited financial statements for the financial year ended 31st March, 2026, the re-appointment of Mr. Haresh Kapurlal Mehta as a Director retiring by rotation, and the re-appointment of Mr. Rishit Haresh Mehta as Whole-Time Director for a further period of three years from 18th September, 2026, to 18th September, 2029. His remuneration will be up to ₹7,50,000 per month, plus benefits, perquisites, allowances, and a 9% bonus. Additionally, the re-appointment of Mr. Haresh Mehta as Chairman & Whole-Time Director for three years from 18th September, 2026, to 18th September, 2029, will be considered, with remuneration also up to ₹7,50,000 per month, plus benefits and a 9% bonus.
The AGM will also consider the increase in remuneration for Mr. Harshit Mehta, Managing Director, effective from 1st October, 2026, for the remaining tenure up to 17th September, 2028, with a basic salary not exceeding ₹7,50,000 per month, plus benefits and a 9% bonus. The company also proposes to increase the professional consultancy fees payable to Ms. Priyal Rishit Mehta, a related party, up to ₹5,00,000 per month from 1st October, 2026. Furthermore, an increase in remuneration payable to Ms. Shweta Harshit Mehta, Regulatory Deputy Manager and a related party, up to ₹5,00,000 per month from 1st October, 2026, will be considered.
The Register of Members and Share Transfer Books will be closed from 16th September, 2026, to 22nd September, 2026, for the AGM. Remote e-voting will be available from 19th September, 2026, to 21st September, 2026.
A plain-language summary of a public exchange filing by Medico Remedies Limited. Read the original for the full detail.